PPD's Dirk Reitsma, vice president of global product development, and William Bakewell, associate director of biopharmaceutical services, discuss strategies that speed follow-on biologicals to market. This webinar focuses on the foundation of the biosimilar strategy—the structural and functional characterization that determines the extent of testing needed to establish similarity.

While diseases such as HIV and malaria affect the global community and threaten world health, vaccines offer hope for eradication or containment of these illnesses. Many vaccine trials are conducted in developing countries where these diseases are prevalent. Unfortunately, inefficient and unreliable infrastructure and lack of clinical research experience in developing countries can present challenges to the success of these trials.

In the past six years, the public’s awareness of morbidity and mortality caused by influenza A has increased significantly, mainly due to two of the disease’s notable strains.